Phillip Andrew Dennis Sells $5.83K of NovaBridge Biosciences (NBP) — SEC Form 4, Sep 21, 2026

Open-Market Net Sale · SEC Form 4
−$5,828

Equity position changed by +9.3%

Reporting Owner
TXN 2026-09-18 · FILED 2026-09-21
Equity Position 182K sh 166,150 → 181,636
Equity Change +9.3% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-21
Report Date
2026-09-21
Accession No.
0002089237-26-000008
Accepted At
2026-09-21 20:05 UTC
Reporting Owner
Name Relationship
Phillip Andrew Dennis CIK 0002089237
Officer
Phillip Andrew Dennis at NovaBridge Biosciences Full insider history
Bought (12 mo) —
Sold (12 mo) $11,434
More from this insider at NovaBridge Biosciences
2026-06-22 Sell -$5,606 View
All filings by this insider at NovaBridge Biosciences
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary SharesF1F2F3F4 2026-09-17 M - Exercise 23,695 A — 181,636 Direct
Ordinary SharesF1F5F6F7 2026-09-18 S - Sale 8,209 D $0.71 -$5,828 173,427 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Restricted Share UnitsF3F8F9F9F1F8F8 2026-09-17 M - Exercise 10,302 D $0.00 10,302 Ordinary Shares Direct
Footnotes (9)
F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
F2
Reported securities are represented by 10,302 ADSs. Show more
F3
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
F4
Reported securities are represented by 78,972 ADSs. Show more
F5
Reported securities are represented by 3,569 ADSs. Show more
F6
Reported sales price represents the converted sales price of the ADSs of $1.6247. Show more
F7
Reported securities are represented by 75,403 ADSs. Show more
F8
Reported securities represent ADSs. Show more
F9
On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at NovaBridge Biosciences
All NovaBridge Biosciences insider activity
GET /v1/forms/4/0002089237-26-000008 API docs
View Original SEC Filing